Here's Grail Stock Soared: What Drove the May Rally and Where It's Heading
In May, Grail stock surged on optimism about FDA approval timing and potential reimbursement for the Galleri MCED tes...
Starting your investment journey? Learn what to watch out for as a new investor to avoid common pitfalls and make wise choices.
27,695 articlesIn May, Grail stock surged on optimism about FDA approval timing and potential reimbursement for the Galleri MCED tes...
Markets have cooled, but big tech still stands out. Here are five names that look unusually affordable, with clear pa...
As Sprinklr (CXM) gears up for 2027 earnings, investors will scrutinize revenue growth, margins, and customer stickin...
The SEC proposes letting companies use semiannual reports to meet interim disclosure duties, potentially easing burde...
The crypto industry is cooling as funding tightens and demand wavers. Syndicate Labs shuts down amid a wave of cost c...
A focused look at a large institutional bet on Indivior, the logic behind the $143 million investment, and how such m...
A sharp market pullback followed a bold political statement about the Iran deal. This guide breaks down what happened...
July markets bring attention to enduring brands and steady income. Coca-Cola's blend of dividend discipline, pricing ...
A single hedge fund exit can move a stock as much as a major earnings beat. This guide breaks down a $34 million TDS ...
Hungry for AI-driven gains and a simpler path to growth, some investors eye the Roundhill Magnificent Seven ETF. This...
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
In Q1 2026, new homes held prices steady while resale values declined, signaling a pricing strategy where discounts r...